Email This

A 35-Year-Old Man With Lower Limb Weakness CME

Patricia K. Coyle, MD; Chris Fischer Author Information and Disclosures

Release Date: June 9, 2008; Valid for credit through August 15, 2008

Credits Available

Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

A 35-Year-Old Man With Lower Limb Weakness

Go to CME Test Questions

Legal Disclaimer

The materials presented here were not produced by eMedicine and do not necessarily reflect the views of eMedicine or companies that support educational programming on www.emedicine.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified health care professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in this educational activity.

This activity has expired.
The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.
CME Information

Learning Objectives

describe the differences between the information derived from T1 and T2 sequencing methods,
identify disease characteristics that place a patient at high risk for progressing from clinically isolated syndrome (CIS) to multiple sclerosis (MS), and
discuss the outcomes of the BENEFIT, CHAMPS, CHAMPIONS, and ETOMS trials and their findings on the effect of disease modifying therapy and the risk of MS.

Author Disclosures

Patricia K. Coyle, MD
Disclosure: Sources of Funding for Research: Bayer HealthCare Pharmaceuticals; Pfizer, Inc; Serono, Inc; and Teva Pharmaceuticals, Ltd.
Consulting Agreements: Bayer HealthCare Pharmaceuticals; Pfizer, Inc; Serono, Inc; and Teva Pharmaceuticals, Ltd.
Speakers Bureau/Honorarium Agreements: Bayer HealthCare Pharmaceuticals; Biogen; Pfizer Inc; Serono, Inc; and Teva Pharmaceuticals, Ltd.
Financial Interests/Stock Ownership: None
Discussion of Off-label, Investigational, or Experimental Drug Use: None

Chris Fischer
Disclosure: Sources of Funding for Research: None
Consulting Agreements: None
Speakers Bureau/Honorarium Agreements: None
Financial Interests/Stock Ownership: None
Discussion of Off-label, Investigational, or Experimental Drug Use: None

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Discovery Institute of Medical Education (DIME). DIME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Discovery Institute of Medical Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider